{"result": "(\"entity\"<|>FRUCTOSA-1,6-BIFOSFATASA<|>PERSON<|>Fructosa-1,6-bifosfatasa is a key enzyme in gluconeogenesis that catalyzes the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate, and its deficiency leads to a metabolic disorder.)\n##\n(\"entity\"<|>GLUCONEOGENESIS<|>EVENT<|>Gluconeogenesis is a metabolic process that generates glucose from non-carbohydrate substrates, which is affected in the case of fructose-1,6-bisphosphatase deficiency.)\n##\n(\"entity\"<|>GLUCOLYSIS<|>EVENT<|>Glycolysis is a metabolic pathway that converts glucose into pyruvate, which is relevant in the context of metabolic disorders.)\n##\n(\"entity\"<|>HIPOGlucemia<|>EVENT<|>Hypoglycemia is a condition characterized by abnormally low blood glucose levels, which can occur in patients with fructose-1,6-bisphosphatase deficiency.)\n##\n(\"entity\"<|>ACIDOSIS LACTICA<|>EVENT<|>Lactic acidosis is a condition that can occur due to the accumulation of lactic acid in the body, often seen in metabolic disorders.)\n##\n(\"entity\"<|>HEPATOMEGALY<|>EVENT<|>Hepatomegaly is the enlargement of the liver, which can occur in patients with metabolic disorders like fructose-1,6-bisphosphatase deficiency.)\n##\n(\"entity\"<|>GLUCOSA<|>PERSON<|>Glucose is a simple sugar that is an important energy source in living organisms and is used in the treatment of metabolic disorders.)\n##\n(\"entity\"<|>ALMIDÓN CRUDO DE MAÍZ<|>PERSON<|>Raw corn starch is a dietary recommendation for patients with metabolic disorders to help manage blood glucose levels.)\n##\n(\"entity\"<|>BICARBONATO SÓDICO<|>PERSON<|>Sodium bicarbonate is used to treat acidosis in patients with metabolic disorders.)\n##\n(\"relationship\"<|>FRUCTOSA-1,6-BIFOSFATASA<|>GLUCONEOGENESIS<|>Fructosa-1,6-bifosfatasa is a key enzyme in the gluconeogenesis pathway, and its deficiency directly impacts this metabolic process.<|>9)\n##\n(\"relationship\"<|>GLUCONEOGENESIS<|>HIPOGlucemia<|>Disruption in gluconeogenesis due to enzyme deficiency can lead to hypoglycemia, especially during prolonged fasting.<|>8)\n##\n(\"relationship\"<|>GLUCONEOGENESIS<|>ACIDOSIS LACTICA<|>Impaired gluconeogenesis can result in lactic acidosis due to the accumulation of lactic acid from alternative metabolic pathways.<|>7)\n##\n(\"relationship\"<|>GLUCONEOGENESIS<|>HEPATOMEGALY<|>Gluconeogenesis impairment can lead to liver complications, including hepatomegaly due to fat accumulation.<|>6)\n##\n(\"relationship\"<|>GLUCOSA<|>HIPOGlucemia<|>Glucose is administered to treat hypoglycemia in patients with metabolic disorders.<|>9)\n##\n(\"relationship\"<|>ALMIDÓN CRUDO DE MAÍZ<|>HIPOGlucemia<|>Raw corn starch is recommended to prevent hypoglycemia by providing a slow release of glucose.<|>8)\n##\n(\"relationship\"<|>BICARBONATO SÓDICO<|>ACIDOSIS LACTICA<|>Sodium bicarbonate is used to treat lactic acidosis in patients with metabolic disorders.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: licina & Treonina & Serina & Triptófano\n    PIRUVATO --> |PIRUVATO DESHIDROGENASA| ACETIL-CoA\n    PIRUVATO --> |PIRUVATO CARBOXILASA| OXALACETATO\n    OXALACETATO --> |FOSFOENOLPIRUVATO CARBOXIKINASA| FOSFOENOLPIRUVATO\n    OXALACETATO <--> |GOT| ASPARTATO\n    OXALACETATO <--> |MALATO DESHIDROGENASA| MALATO\n    \n    subgraph Citosol\n    end\n    \n    subgraph Mitocondria\n    end\n    \n    GLICEROL --> |GLICEROL KINASA| GLICEROL-3-FOSFATO\n    GLICEROL-3-FOSFATO --> |GLICEROL-3-FOSFATO DESHIDROGENASA| DIHIDROXIACETONA-FOSFATO\n    \n    ACETIL-CoA --> |Ciclo de Krebs| OXALACETATO\n    \n    subgraph GLUCÓLISIS\n        direction LR\n    end\n    \n    subgraph GLUCONEOGÉNESIS\n        direction RL\n    end\n```\n\nFigura 5. Glucólisis y gluconeogénesis.\n---\nTema 14. Soporte nutricional en patologías con alteración en el procesamiento... 235\n\nEn este capítulo trataremos el único defecto enzimático de la gluconeogénesis que se beneficia de modificaciones nutricionales.\n\n## 4.1. Déficit de fructosa-1,6-bifosfatasa\n\nEs una enfermedad autosómica recesiva, producida por el déficit de fructosa-1,6-bifosfatasa, enzima clave de la gluconeogénesis que cataliza el paso de fructosa-1,6-bifosfato a fructosa-6-fosfato. Como está afectada la gluconeogénesis pero no la glucogenólisis, solo se producirá hipoglucemia en las situaciones de ayuno prolongado.\n\nLas manifestaciones clínicas son similares a la GSDI, aunque sin acumulación de glucógeno en el hígado, ya que la glucogenólisis es normal. El comienzo de la sintomatología es variable; en aproximadamente la mitad de los casos se presenta precozmente a las pocas horas del nacimiento con hipoglucemia, cetosis, acidosis láctica, hiperlipidemia, hiperuricemia, somnolencia, hiperventilación, taquicardia, y hasta convulsiones y coma, pero se han descrito presentaciones a muy diversas edades desencadenadas fundamentalmente por episodios infecciosos. Se produce acumulación de ácidos grasos en el hígado, con esteatosis hepática y fibrosis, que se manifiesta como una hepatomegalia leve (no hepatomegalia masiva de GSD) y posible hiperbilirrubinemia.\n\nDebe sospecharse ante la clínica de hipoglucemia acompañada de incremento de piruvato, sustratos neoglucogénicos (lactato, alanina y glicerol) y cuerpos cetónicos (existen algunos casos sin cetosis), y acidosis metabólica (por desviación hacia la síntesis de láctico y el incremento de la cetonemia). El diagnóstico se confirma mediante estudio genético, o en caso negativo pero con alta sospecha, cuantificación de la actividad enzimática en biopsia hepática.\n\n### 4.1.1. Objetivos nutricionales y recomendaciones dietéticas\n\nEl objetivo del tratamiento es evitar la puesta en marcha de la gluconeogénesis para prevenir la aparición de hipoglucemias, acidosis láctica y resto de manifestaciones, así como permitir un desarrollo adecuado. Esto se consigue evitando períodos largos de ayuno mediante una dieta con frecuentes tomas y un aporte alto de HC complejos. Al igual que en la GSDI, en los recién nacidos se requiere una infusión enteral continua nocturna de glucosa o una fórmula polimérica, y a medida que pasan los años y mejora la tolerancia al ayuno los pacientes pueden mantenerse con la ingesta de almidón crudo de maíz antes de dormir (véase GSDI).\n\n### 4.1.2. Soporte nutricional artificial\n\nEn recién nacidos se recomienda utilizar una perfusión continua de glucosa y tratar la acidosis con bicarbonato sódico. Si ésta no se corrige, se debe aumentar el aporte de glucosa y administrar insulina conjuntamente (0,02-0,1 UI/kg/h), puesto que mejora la síntesis proteica y de ácidos grasos a partir del piruvato. Las recomendaciones sobre la nutrición enteral nocturna son similares a la GSDI.\n\nEn situaciones de enfermedad, en las que se produce un incremento del catabolismo, aumenta el riesgo de acidosis láctica\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}